This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I received good feedback on Tuesday's video about retail pharmacy. So below, you'll find another brief video excerpt from my May 1 Industry Update and COVID-19 Impact video webinar. In this clip, I highlight the growth and consolidation dynamics facing the specialty pharmacy industry. I also discuss the competitive challenges facing smaller pharmacies.
In this episode, I’ll discuss whether the dose of enoxaparin for VTE prophylaxis can be reduced in low weight patients. Episode 504: Can the dose of enoxaparin for VTE prophylaxis be reduced in low weight patients? Subscribe on iTunes , Android , or Stitcher Shout out to “Pharmacy Jeff” for inspiring this episode! When using enoxaparin for VTE prophylaxis in low-weight adults, doses can approach the 1 mg/kg normally associated with VTE treatment.
I do get quite a few questions from time to time and try to answer as many emails as I can. Here were a few really good questions that I thought I would share with all of you. Can we use ciprofloxacin for pneumonia? Why isn’t ciprofloxacin a treatment in community-acquired pneumonia? Also, why is […]. The post Ciprofloxacin for Pneumonia?
Thanks to everyone who joined me for DCI's Industry Update and COVID-19 Impact video webinars. I enjoyed putting these events together and hope you benefited from watching them. If you missed these two live events, click here to find out how you can watch the replays. Below is a brief video excerpt from my May 1 video webinar. In this clip, I summarize the perilous competitive dynamics facing retail pharmacies.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
In this episode, I’ll discuss an article about IVP antibiotic safety. Episode 503: Safety of IV push antibiotics Subscribe on iTunes , Android , or Stitcher Article Safety of intravenous push administration of beta-lactams within a healthcare system Lead author: Kassandra Marsh, PharmD, BCIDP Published in American Journal of Health-System Pharmacy April 2020 Background In the aftermath of hurricane disruptions to IV solution supply chains, 2017 saw a severe minibag shortage.
Loop diuretics are the mainstay in removing fluid off the body in patients with heart failure. They are very common in clinical practice. What should you think about when monitoring loop diuretics? Monitoring Loop Diuretics – Benefit? One of the challenges with polypharmacy in our geriatric patient population is to continually assess the benefit of […].
Loop diuretics are the mainstay in removing fluid off the body in patients with heart failure. They are very common in clinical practice. What should you think about when monitoring loop diuretics? Monitoring Loop Diuretics – Benefit? One of the challenges with polypharmacy in our geriatric patient population is to continually assess the benefit of […].
40
40
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content